Gregory Lucier - Invuity Insider

IVTY -- USA Stock  

USD 7.35  0.025  0.34%

  Chairman
Mr. Gregory T. Lucier was appointed as Chairman of the Board of the Company., effective December 31, 2015. Mr. Lucier has served as a member of our board of directors since October 2014 and as the Chairman of our board of directors since December 2015. Since May 2015, Mr. Lucier has served as the Chief Executive Officer of NuVasive, a publicly traded medical device company. From November 2008 to February 2014, Mr. Lucier was Chairman of the board of directors and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. In May 2003, Mr. Lucier joined Life Technologies predecessor company, Invitrogen Corporationrationration, as Chief Executive Officer. Prior to Life Technologies, Mr. Lucier was a corporate officer at General Electric Company from 1994 to 2003 where he served in a variety of leadership roles. Mr. Lucier serves on the board of directors of NuVasive and Catalent, Inc
Age: 52  Chairman Since 2015  MBA    
415-665-2100  http://www.invuity.com
Lucier received a B.S. with honors in industrial engineering from Pennsylvania State University and an M.B.A. from Harvard Business School. We believe Mr. Lucier is qualified to serve as a member of our board of directors because of his management and operational experience in the healthcare industry.

Gregory Lucier Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (481.4) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.66 M in liabilities. Invuity has Current Ratio of 2.09 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 14 records

CHAIRMAN Since

Richard MeeliaHaemonetics Corporation
2011
John McDermottEndologix
N/A
Joseph FeldschuhDaxor Corporation
2016
Thomas BenderThe Cooper Companies
2007
Robert ParkinsonBaxter International
2016
Ronald GelbmanHaemonetics Corporation
2016
J ErricoElectrocore
2016
Andrew MakridesBovie Medical Corporation
2013
Allan RubensteinThe Cooper Companies
2002
David WatkinsCantel Medical Corp
2009
Steven ShermanEkso Bionics Holdings
2014
Charles DikerCantel Medical Corp
1986
Vincent ForlenzaBecton Dickinson and Company
2017
Jose AlmeidaBaxter International
2016

Entity Summary

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 161 people.Invuity (IVTY) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 161 people. Invuity is listed under Medical Equipment category by Fama And French industry classification.

Invuity Leadership Team

Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Stock Performance Indicators

Did you try this?

Run Chance of Distress Now

   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Search macroaxis.com